InsidersTradesSigma
Browse the detailed record of transactions filed by KOVEN ANDREW I, Director. Director active across 1 companies, notably Kala Pharmaceuticals, Inc.. In total, 2 reports have been recorded. The latest transaction was disclosed on 17 June 2021 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
2 of 2 declarations
Andrew I. Koven is a Board Member at Kala Pharmaceuticals, Inc. He plays a key role in overseeing the company's operations and formulating its strategy. His experience in the pharmaceutical sector is an asset for the company's development.